Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Transverse Myelitis
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
127
Start Date:
July 16, 2021
A Multicenter, Single Arm, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Biological
Participants:
9
Start Date:
March 20, 2021
A Phase 1/2a Open-Label Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Transverse Myelitis (TM)
Search for trials
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Device
Participants:
42
Start Date:
February 8, 2021
High Frequency Impulse Therapy for Neuropathic Pain in NMOSD
Clinical Trial
Status:
Recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Behavioral
Participants:
50
Start Date:
January 1, 2021
Home Based Tele-exercise for People With Chronic Neurological Impairments
Clinical Trial
Status:
Recruiting
Intervention Type:
Drug
Participants:
350
Start Date:
October 31, 2020
Study on the Association Between the Effect of Glucocorticoid Pulse Therapy on Neuromyelitis Optica and Gene Polymorphism: a Cohort Study
Clinical Trial
Status:
Recruiting
Phase:
Early Phase 1
Intervention Type:
Biological, Drug
Participants:
12
Start Date:
September 22, 2020
An Open Label Clinical Trial to Evaluate the Safety and Efficacy of CT103A Cells for the Treatment of Relapsed/Refractory Antibody-associated Idiopathic Inflammatory Diseases of the Nervous System
Clinical Trial
Status:
Recruiting
Phase:
N/A
Intervention Type:
Procedure
Participants:
30
Start Date:
June 15, 2020
IMCY-NMO-000 In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized Neuromyelitis Optica (PHASE 0)
Clinical Trial
Status:
Recruiting
Participants:
200
Start Date:
May 15, 2020
An Diagnostic Cohort on Applicability and Accuracy of AQP4-Immunoglobulin G Detection Kit in the Diagnosis of Neuromyelitis Optica Spectrum Disorders
Clinical Trial
Status:
Recruiting
Intervention Type:
Other
Participants:
2000
Start Date:
April 20, 2020
Cohort Study Evaluating the Epidemiological Characteristics of Coronavirus Infection (SARS-CoV-2) in Patients With MS or NMO
Clinical Trial
Status:
Recruiting
Phase:
Phase 1
Intervention Type:
Drug
Participants:
12
Start Date:
March 31, 2020
Safety, Tolerability, Pharmacodynamics and Efficacy of HBM9161 Weekly Subcutaneous Administration in Patients With Neuromyelitis Optica Spectrum Disorders (NMOSD) in China
Clinical Trial
Status:
Recruiting
Phase:
Phase 2/Phase 3
Intervention Type:
Drug
Participants:
15
Start Date:
January 14, 2020
A Phase 2/3 Open-Label, Single-Arm Trial to Evaluate the Safety and Activity of Eculizumab in Pediatric Patients With Relapsing Neuromyelitis Optica Spectrum Disorder
Clinical Trial
Status:
Recruiting
Phase:
Phase 3
Intervention Type:
Biological
Participants:
55
Start Date:
December 13, 2019
A Phase 3, External Placebo-Controlled, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)
Showing 1-12 of 35
Next